ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 730

Energy Levels: An Overlooked Element in Patient Assessment in Scleroderma

Yossra Suliman1, Suzanne Kafaja 2, Mohamed Alemam 3 and Daniel Furst 4, 1Rheumatology and Rehabilitation Department. Faculty of Medicine. Assiut University, Assiut, Egypt, 2Department of Medicine. Rheumatology Division. UCLA, Los Angeles, CA, 3Clinical Pathology and Chemistry Department. Qena Faculty of Medicine. South Valley University, Assiut, Egypt, 4University of California, Los Angeles, CA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: and fatigue, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Systemic Sclerosis & Related Disorders – Clinical Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Scleroderma (SSc) is a debilitating multi-system chronic disease which directly affects patient related Quality of Life. We wanted to identify how the patient interprets their inability to work and get their perspective on energy levels during daily activities. We hypothesized that there are abnormal constitutional symptoms in SSc patients (i.e. energy levels, sleep quality and time to feeling fatigued) which may directly affect patient productivity. Objective

  • To assess the proportion of SSc patients with abnormal energy levels, sleep and with early fatigue.
  • To evaluate the relation between energy levels  and sleep quality, time to fatigue, pain visual analogue scale (VAS), Pt global VAS, MD global VAS.

Methods: Eighty -five SSc patients meeting the ACR/EULAR 2013 SSc criteria were recruited from Pacific Arthritis Scleroderma Clinic. Laboratory and clinical data were obtained from charts for statistical correlations. Data were cross-sectional and were from the first clinical record available, usually the first clinical visit.

Energy levels were assessed by the question “how is your energy?” and Sleep was ascertained as: ” How well do you sleep?”  or “How is your sleep?” For these questions, answers were categorical: “Good” (0), “OK” (1), “Fair”(2) or” Low”(3).

Fatigue was ascertained as “How long after you get up ,do you start to get tired or fatigued?”. Answers were in hours, including 0 for fatigued immediately upon awakening to 12+(maximum); responses were in 0.5-hour increments. Regression modelling used energy levels as the dependent variable and time to fatigue , sleep quality, pain VAS, pt global, MD global as independent variables.

Results: The 85 SSc patients’ characteristics were as follows: mean age 55 (13%), female 76 ILD (37), mean MRSS 7 (±7.5) Table 1. Energy levels were fair-poor in more than 50%, while significantly shortened time to fatigue (< =3 hrs) occurred in 29(34%) ) . Sleep quality was only fair-poor in 37/85(43%) Table 2. Regression model identified fatigue,  sleep , pain VAS, patient global and MD  as strong predictors of Energy levels in SSc pts (p =0.0001, 0.0001, 0.009,0.0001 and 0.0001 respectively).

Conclusion: Energy levels among other constitutional symptoms (ie, sleep and fatigue ) are significantly altered in SSc patients, more care is to be given to address possible causes , assessment tools and to  improve management plans.


Disclosure: Y. Suliman, None; S. Kafaja, None; M. Alemam, None; D. Furst, Actelion, 2, 5, Actelion Pharmaceuticals, 2, 5, Amgen, 2, 5, BMS, 2, 5, CME, 5, 8, Corbus, 2, 5, Galapagos, 2, 5, Galapogos Novartis, 5, GlaxoSmithKline, 2, GSK, 2, 5, NIH, 2, Novartis, 2, 5, Pfizer, 2, 5, Roche/Genentech, 2, 5, Sanofi, 2, 5.

To cite this abstract in AMA style:

Suliman Y, Kafaja S, Alemam M, Furst D. Energy Levels: An Overlooked Element in Patient Assessment in Scleroderma [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/energy-levels-an-overlooked-element-in-patient-assessment-in-scleroderma/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/energy-levels-an-overlooked-element-in-patient-assessment-in-scleroderma/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology